Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 1 January 2020)


Open article in different language:  DE  |  FR  |  IT
Art. 34 Labelling

1 Blood and labile blood products and the cor­res­pond­ing blood samples must be la­belled in ac­cord­ance with the rules of GMP and good prac­tice in ac­cord­ance with An­nex 1 of the Or­din­ance of 29 April 20157 on Mi­cro­bi­o­lo­gic­al Labor­at­or­ies.

2 In the case of auto­log­ous trans­fu­sion, the la­bel must also bear the name of the donor and the la­bel must be signed by the auto­log­ous donor im­me­di­ately be­fore blood col­lec­tion.

3 Auto­log­ous dona­tions must be kept sep­ar­ate from ho­mo­log­ous dona­tions.

7 SR 818.101.32

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden